Breaking News Instant updates and real-time market news.

AUPH

Aurinia Pharmaceuticals

$4.70

-0.4 (-7.84%)

, GLPG

Galapagos NV

$65.10

-0.41 (-0.63%)

08:30
10/10/16
10/10
08:30
10/10/16
08:30

Three new option listings on October 10th

New option listings for October 10th include Aurinia Pharmaceuticals (AUPH), Galapagos NV (GLPG), and Nutanix Inc (Class A Stock) (NTNX).

AUPH

Aurinia Pharmaceuticals

$4.70

-0.4 (-7.84%)

GLPG

Galapagos NV

$65.10

-0.41 (-0.63%)

NTNX

Nutanix

$38.15

1.45 (3.95%)

  • 06

    Nov

AUPH Aurinia Pharmaceuticals
$4.70

-0.4 (-7.84%)

06/30/16
HCWC
06/30/16
INITIATION
Target $7
HCWC
Buy
Aurinia Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce started Aurinia Pharmaceuticals with a Buy rating and $7 price target.
GLPG Galapagos NV
$65.10

-0.41 (-0.63%)

06/16/16
LEER
06/16/16
NO CHANGE
Target $104
LEER
Outperform
Vertex remains ahead in cystic fibrosis, says Leerink
During their Annual R&D Update, Leerink analyst Geoffrey Porges says Galapagos (GLPG) presented the development plans for its cystic fibrosis franchise, in partnership with AbbVie (ABBV), which is a current threat to Vertex (VRTX). The announcement represents an "aggressive timeline" that would allow for a pivotal phase 3 for Galapagos' triple combination to begin in 2018 as a best case scenario, Porges tells investors in a research note. Nonetheless, the analyst believes Vertex's next generation combinations are much further along in development, with the company currently having a number of dual combination phase 3 trials underway. Porges reiterates an Outperform rating and $104 price target on Vertex's shares.
08/30/16
JANY
08/30/16
INITIATION
Target $64
JANY
Buy
Galapagos NV initiated with a Buy at Janney Capital
Janney Capital analyst Debjit Chattopadhyay initiated Galapagos NV with a Buy rating and $64 fair value estimate, saying that filgotinib, the company's oral JAK inhibitor, is "shaping up to be a blockbuster," but noting as well that the company's Cystic Fibrosis program will dominate headlines over the next six to nine months.
08/30/16
08/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BofA Merrill Lynch resumed coverage on Hershey (HSY) with an Underperform rating and $100 price target, as the firm expects shares to trade on fundamentals, which are under pressure. Last night, Mondelez (MDLZ) announced it has ended discussions with Hershey regarding a possible combination of the two companies. 2. eBay (EBAY) initiated with a Long-Term Buy at Hilliard Lyons by analyst Stephen Turner , who set a $35 price target on the stock. 3. Galapagos NV (GLPG) initiated with a Buy at Janney Capital by Debjit Chattopadhyay, who said that filgotinib, the company's oral JAK inhibitor, is "shaping up to be a blockbuster." 4. Gemphire Therapeutics (GEMP) initiated with with a Buy rating and $17 price target by Canaccord Genuity analyst John Newman and with a Buy rating and $15 price target by Jefferies analyst Matthew Andrews. 5. Sophiris Bio (SPHS) initiated with an an Overweight rating and $7 price target by Piper Jaffray analyst Charles Duncan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/16
JANY
09/22/16
NO CHANGE
Target $64
JANY
Buy
Galapagos drug more important to Gilead after trial halt, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said Gilead Sciences' (GILD) termination of its combined Phase 2/3 study of GS-5745 in ulcerative colitis implies that Galapagos (GLPG) filgotinib is now potentially more important to Gilead's growth prospects. The analyst, who thinks upcoming data could provide meaningful upside for Galapagos shares even after the stock's 25% move up over the past three weeks, keeps a Buy rating and $64 fair value estimate on the stock.
NTNX Nutanix
$38.15

1.45 (3.95%)

09/30/16
MAXM
09/30/16
INITIATION
Target $40
MAXM
Buy
Nutanix initiated with a Buy at Maxim
Maxim initiated Nutanix with a Buy and a $40. The company priced 14.9M share IPO at $16 today.

TODAY'S FREE FLY STORIES

INN

Summit Hotel Properties

$15.46

0.1 (0.65%)

05:20
09/26/17
09/26
05:20
09/26/17
05:20
Upgrade
Summit Hotel Properties rating change  »

Summit Hotel Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

DRE

Duke Realty

$29.28

0.17 (0.58%)

05:17
09/26/17
09/26
05:17
09/26/17
05:17
Downgrade
Duke Realty rating change  »

Duke Realty downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REXR

Rexford Industrial

$29.56

0.05 (0.17%)

05:15
09/26/17
09/26
05:15
09/26/17
05:15
Downgrade
Rexford Industrial rating change  »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

$50.00

0.86 (1.75%)

05:14
09/26/17
09/26
05:14
09/26/17
05:14
Downgrade
Taubman Centers rating change  »

Taubman Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 11

    Oct

KIM

Kimco Realty

$19.58

0.4 (2.09%)

05:11
09/26/17
09/26
05:11
09/26/17
05:11
Upgrade
Kimco Realty rating change  »

Kimco Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

GGP

GGP

$20.75

0.25 (1.22%)

05:11
09/26/17
09/26
05:11
09/26/17
05:11
Upgrade
GGP rating change  »

GGP upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAC

Macerich

$54.16

1.44 (2.73%)

05:10
09/26/17
09/26
05:10
09/26/17
05:10
Upgrade
Macerich rating change  »

Macerich upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DY

Dycom

$81.23

-1.46 (-1.77%)

05:06
09/26/17
09/26
05:06
09/26/17
05:06
Initiation
Dycom initiated  »

Dycom initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PNC

PNC Financial

$133.52

0.09 (0.07%)

, GS

Goldman Sachs

$230.26

-0.77 (-0.33%)

05:04
09/26/17
09/26
05:04
09/26/17
05:04
Downgrade
PNC Financial, Goldman Sachs, Wells Fargo, Morgan Stanley, JPMorgan rating change  »

PNC Financial downgraded…

PNC

PNC Financial

$133.52

0.09 (0.07%)

GS

Goldman Sachs

$230.26

-0.77 (-0.33%)

WFC

Wells Fargo

$54.03

-0.22 (-0.41%)

MS

Morgan Stanley

$47.74

-0.48 (-1.00%)

JPM

JPMorgan

$94.12

-0.71 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 12

    Oct

  • 13

    Oct

  • 13

    Oct

  • 17

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

JPM

JPMorgan

$94.12

-0.71 (-0.75%)

05:01
09/26/17
09/26
05:01
09/26/17
05:01
Downgrade
JPMorgan rating change  »

JPMorgan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 12

    Oct

  • 22

    Oct

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

JWN

Nordstrom

$47.32

0.44 (0.94%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Nordstrom management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BMY

Bristol-Myers

$63.19

-0.17 (-0.27%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Bristol-Myers management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

MCO

Moody's

$138.78

0.75 (0.54%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Moody's management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

ALB

Albemarle

$128.89

-5.4 (-4.02%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Albemarle management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

AFSI

AmTrust

$12.98

-0.3 (-2.26%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
AmTrust management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NEE

NextEra Energy

$146.82

0.46 (0.31%)

, AES

AES Corp.

$11.21

0.1 (0.90%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Wolfe Research to hold a conference »

Utilities & Power…

NEE

NextEra Energy

$146.82

0.46 (0.31%)

AES

AES Corp.

$11.21

0.1 (0.90%)

PEGI

Pattern Energy

$25.53

-0.37 (-1.43%)

LNT

Alliant Energy

$42.25

0.52 (1.25%)

AGR

Avangrid

$47.10

0.6 (1.29%)

PNW

Pinnacle West

$86.85

0.7 (0.81%)

ETR

Entergy

$77.76

1.01 (1.32%)

PEG

PSEG

$46.50

0.31 (0.67%)

AWK

American Water

$82.48

0.45 (0.55%)

CMS

CMS Energy

$47.10

0.63 (1.36%)

AEP

American Electric

$71.04

0.47 (0.67%)

D

Dominion

$78.02

0.98 (1.27%)

ED

Consolidated Edison

$82.24

0.65 (0.80%)

ES

Eversource

$61.47

0.76 (1.25%)

EIX

Edison International

$79.27

0.99 (1.26%)

DUK

Duke Energy

$85.14

0.89 (1.06%)

DTE

DTE Energy

$109.74

1.36 (1.25%)

FE

FirstEnergy

$31.11

0.22 (0.71%)

WEC

WEC Energy

$64.24

0.63 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

  • 02

    Oct

  • 05

    Nov

  • 29

    Nov

DNOW

NOW Inc.

$13.26

0.27 (2.08%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
NOW Inc. management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 01

    Nov

ALGT

Allegiant Travel

$133.95

3.85 (2.96%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Allegiant Travel management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XPER

Xperi

$24.70

-0.35 (-1.40%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Xperi management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

OZRK

Bank of the Ozarks

$45.90

0.34 (0.75%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Bank of the Ozarks management to meet with Piper Jaffray »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 29

    Sep

04:55
09/26/17
09/26
04:55
09/26/17
04:55
General news
Consumer Confidence to be reported at 10:00 »

September Consumer…

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Citigroup to hold a forum »

Pan Asia Corporate Forum…

BGG

Briggs & Stratton

$22.93

0.24 (1.06%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PLUS

ePlus

$87.95

-0.65 (-0.73%)

04:55
09/26/17
09/26
04:55
09/26/17
04:55
Conference/Events
ePlus management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

04:55
09/26/17
09/26
04:55
09/26/17
04:55
General news
Breaking General news story  »

Federal Reserve Chair…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.